Long-term effects of pancreas transplant alone on nephropathy in type 1 diabetic patients with optimal renal function.

Limited data are available regarding optimal selection criteria for pancreas transplant alone (PTA) to minimize aggravation of diabetic nephropathy.A total of 87 type 1 diabetic patients were evaluated before and after PTA at a single center from January, 1999 to December, 2015, together with 87 mat...

Full description

Bibliographic Details
Main Authors: Sung Shin, Chang Hee Jung, Ji Yoon Choi, Hyun Wook Kwon, Joo Hee Jung, Young Hoon Kim, Duck Jong Han
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5788334?pdf=render
_version_ 1811336753312694272
author Sung Shin
Chang Hee Jung
Ji Yoon Choi
Hyun Wook Kwon
Joo Hee Jung
Young Hoon Kim
Duck Jong Han
author_facet Sung Shin
Chang Hee Jung
Ji Yoon Choi
Hyun Wook Kwon
Joo Hee Jung
Young Hoon Kim
Duck Jong Han
author_sort Sung Shin
collection DOAJ
description Limited data are available regarding optimal selection criteria for pancreas transplant alone (PTA) to minimize aggravation of diabetic nephropathy.A total of 87 type 1 diabetic patients were evaluated before and after PTA at a single center from January, 1999 to December, 2015, together with 87 matched non-transplanted type 1 diabetic subjects who were candidates for PTA to compare deterioration of native kidney function. A total of 163 patients (79 in the transplanted group and 84 in the nontransplanted group) were finally enrolled after excluding nine patients with estimated glomerular filtration rate less than 60 mL/min/1.73 m2 and two patients with moderate proteinuria (≥ 1.5 g/day).A total of seven recipients (8.9%) had end-stage renal disease post-transplant whereas only one patient (1.2%) developed end-stage renal disease in the nontransplanted group during their follow-up period (median 12.0, range 6-96 months) (p = 0.03). Furthermore, a composite of severe renal dysfunction and end-stage renal disease (31.6% vs 2.4%) was significantly higher in the transplanted group (p < 0.001). Multivariate Cox regression analysis revealed that a higher level of tacrolimus at six months post-transplant (HR = 1.648, CI = 1.140-2.385, p = 0.008) was the only significant factor associated with end-stage renal disease.There is a considerable risk for deterioration of renal function in PTA recipients post-transplant compared with non-transplant diabetic patients. With rather strict selection criteria such as preoperative proteinuria and estimated glomerular filtration rate, PTA should be considered in diabetic patients to minimize post-transplant aggravation of diabetic nephropathy.
first_indexed 2024-04-13T17:44:13Z
format Article
id doaj.art-594ed17780ed4e45b14f7e64a0134692
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T17:44:13Z
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-594ed17780ed4e45b14f7e64a01346922022-12-22T02:37:04ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01131e019142110.1371/journal.pone.0191421Long-term effects of pancreas transplant alone on nephropathy in type 1 diabetic patients with optimal renal function.Sung ShinChang Hee JungJi Yoon ChoiHyun Wook KwonJoo Hee JungYoung Hoon KimDuck Jong HanLimited data are available regarding optimal selection criteria for pancreas transplant alone (PTA) to minimize aggravation of diabetic nephropathy.A total of 87 type 1 diabetic patients were evaluated before and after PTA at a single center from January, 1999 to December, 2015, together with 87 matched non-transplanted type 1 diabetic subjects who were candidates for PTA to compare deterioration of native kidney function. A total of 163 patients (79 in the transplanted group and 84 in the nontransplanted group) were finally enrolled after excluding nine patients with estimated glomerular filtration rate less than 60 mL/min/1.73 m2 and two patients with moderate proteinuria (≥ 1.5 g/day).A total of seven recipients (8.9%) had end-stage renal disease post-transplant whereas only one patient (1.2%) developed end-stage renal disease in the nontransplanted group during their follow-up period (median 12.0, range 6-96 months) (p = 0.03). Furthermore, a composite of severe renal dysfunction and end-stage renal disease (31.6% vs 2.4%) was significantly higher in the transplanted group (p < 0.001). Multivariate Cox regression analysis revealed that a higher level of tacrolimus at six months post-transplant (HR = 1.648, CI = 1.140-2.385, p = 0.008) was the only significant factor associated with end-stage renal disease.There is a considerable risk for deterioration of renal function in PTA recipients post-transplant compared with non-transplant diabetic patients. With rather strict selection criteria such as preoperative proteinuria and estimated glomerular filtration rate, PTA should be considered in diabetic patients to minimize post-transplant aggravation of diabetic nephropathy.http://europepmc.org/articles/PMC5788334?pdf=render
spellingShingle Sung Shin
Chang Hee Jung
Ji Yoon Choi
Hyun Wook Kwon
Joo Hee Jung
Young Hoon Kim
Duck Jong Han
Long-term effects of pancreas transplant alone on nephropathy in type 1 diabetic patients with optimal renal function.
PLoS ONE
title Long-term effects of pancreas transplant alone on nephropathy in type 1 diabetic patients with optimal renal function.
title_full Long-term effects of pancreas transplant alone on nephropathy in type 1 diabetic patients with optimal renal function.
title_fullStr Long-term effects of pancreas transplant alone on nephropathy in type 1 diabetic patients with optimal renal function.
title_full_unstemmed Long-term effects of pancreas transplant alone on nephropathy in type 1 diabetic patients with optimal renal function.
title_short Long-term effects of pancreas transplant alone on nephropathy in type 1 diabetic patients with optimal renal function.
title_sort long term effects of pancreas transplant alone on nephropathy in type 1 diabetic patients with optimal renal function
url http://europepmc.org/articles/PMC5788334?pdf=render
work_keys_str_mv AT sungshin longtermeffectsofpancreastransplantaloneonnephropathyintype1diabeticpatientswithoptimalrenalfunction
AT changheejung longtermeffectsofpancreastransplantaloneonnephropathyintype1diabeticpatientswithoptimalrenalfunction
AT jiyoonchoi longtermeffectsofpancreastransplantaloneonnephropathyintype1diabeticpatientswithoptimalrenalfunction
AT hyunwookkwon longtermeffectsofpancreastransplantaloneonnephropathyintype1diabeticpatientswithoptimalrenalfunction
AT jooheejung longtermeffectsofpancreastransplantaloneonnephropathyintype1diabeticpatientswithoptimalrenalfunction
AT younghoonkim longtermeffectsofpancreastransplantaloneonnephropathyintype1diabeticpatientswithoptimalrenalfunction
AT duckjonghan longtermeffectsofpancreastransplantaloneonnephropathyintype1diabeticpatientswithoptimalrenalfunction